Invesco Nasdaq Biotechnology ETF (IBBQ)
20.43
+0.07
(+0.34%)
USD |
NASDAQ |
May 23, 16:00
20.43
0.00 (0.00%)
After-Hours: 20:00
Key Stats
Customize
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.19% | 0.10% | 35.72M | 15890.37 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.81% | 19.00% | 7.721M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of the Nasdaq Biotechnology Index, which is designed to measure the performance of securities that are classified as either biotechnology or pharmaceutical companies. The Fund generally will invest at least 90% of its total assets in the securities that comprise the Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Invesco |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 24, 2025.
Asset Allocation
As of April 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.00% |
| Stock | 100.0% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of the Nasdaq Biotechnology Index, which is designed to measure the performance of securities that are classified as either biotechnology or pharmaceutical companies. The Fund generally will invest at least 90% of its total assets in the securities that comprise the Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Invesco |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |